日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction: A Randomized Clinical Trial

院内PCSK9抑制剂对心肌梗死后心肌炎症的影响:一项随机临床试验

Ziogos, Efthymios; Harb, Tarek; Valenta, Ines; Vavuranakis, Michael A; Foran, Palmer L; Williams, Marlene S; Blaha, Michael J; Hays, Allison G; Jones, Steven R; Schindler, Thomas H; Schulman, Steven P; Gerstenblith, Gary; Leucker, Thorsten M

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition.

急性冠脉综合征中血小板活化和内皮功能障碍生物标志物:PCSK9 抑制的影响

Ziogos Efthymios, Chelko Stephen P, Harb Tarek, Engel Morgan, Vavuranakis Michael A, Landim-Vieira Maicon, Walsh Elise M, Williams Marlene S, Lai Shenghan, Halushka Marc K, Gerstenblith Gary, Leucker Thorsten M

Lipoprotein(a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up

急性心肌梗死患者的脂蛋白(a)浓度并不能预测六个月随访时的水平。

Ziogos, Efthymios; Vavuranakis, Michael A; Harb, Tarek; Foran, Palmer L; Blaha, Michael J; Jones, Steven R; Lai, Shenghan; Gerstenblith, Gary; Leucker, Thorsten M

Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized Trial

依洛尤单抗对围梗死期和早期梗死后动脉粥样硬化脂蛋白的影响:一项安慰剂对照随机试验

Leucker, Thorsten M; Blaha, Michael J; Jones, Steven R; Vavuranakis, Michael A; Williams, Marlene S; Lai, Hong; Schindler, Thomas H; Latina, Jacqueline; Schulman, Steven P; Gerstenblith, Gary

The role of Lipoprotein(a) in cardiovascular disease: Current concepts and future perspectives

脂蛋白(a)在心血管疾病中的作用:当前概念和未来展望

Vavuranakis, Michael A; Jones, Steven R; Cardoso, Rhanderson; Gerstenblith, Gary; Leucker, Thorsten M